Characterization of BAM8-22 as a New Surrogate Model of Non-histaminergic Itch

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

May 1, 2021

Study Completion Date

June 1, 2021

Conditions
Itch
Interventions
DRUG

BAM8-22

Bovine Adrenal Medulla will be applied to 2 previously determined area on the volar forearm (one alone and one in combination with doxepin)

DRUG

Histamine

histamine will be applied to 2 previously determined area on the volar forearm (one alone and one in combination with doxepin)

DRUG

Cowhage (Mucuna Pruriens)

cowhage spicules will be applied to 2 previously determined area on the volar forearm (one alone and one in combination with doxepin)

DRUG

Doxepin

Doxepin cream (antihistamine) will be applied in 4 areas on the volar forearm

Trial Locations (1)

9000

Aalborg University, Aalborg

All Listed Sponsors
lead

Aalborg University

OTHER

NCT04588532 - Characterization of BAM8-22 as a New Surrogate Model of Non-histaminergic Itch | Biotech Hunter | Biotech Hunter